应急喷淋洗眼器网

• 复合式洗眼器
• 立式洗眼器
• 壁挂式洗眼器
• 便携式洗眼器
• 台式洗眼器
• 喷淋器、喷淋头
• 紧急洗眼站
• 电伴热洗眼器
• 电加热洗眼器
• 地上式自动排空防冻型洗眼器
• 地埋式自动排空防冻型洗眼器
• 高性能抗腐蚀洗眼器
• 洗眼器配件
• 特价洗眼器

   TCC设计的BLUESTAR ADISSEO的洗眼器由斯壮格（STG）中标。

安迪苏公司是世界三大营养添加剂生产厂商之一，2006年1月成为蓝星的全资子公司，以专业生产蛋氨酸、维生素、酶制剂和过瘤胃蛋氨酸系列产品为主，是全球唯一一家可生产固体和液体蛋氨酸的企业。公司生产和销售14种单项维生素或复合维生素，尤其以麦可维TMA超性能型1000独占世界鳌头，具有抗膨化和过瘤胃特性。通用型天然复合酶是公司的高技术新产品，有粉剂和液体两个品种。目前，公司利用自身的先进技术和设备将产品扩展至人类应用领域，如食品、药品和化妆品等。

Bluestar Adisseo Nutrition Group, the French animal-nutrition feed additives producer backed by China National Chemical Corp, said Wednesday that it sees huge potential for business growth on the mainland.

The company believes that its products can help raise the productivity of the country's animal husbandry amid tight meat supply that has helped fuel inflation.

"Methionine could reduce the cost of poultry breeding by more than 20 percent, which will not just benefit the farmers but also help control prices amid an environment of price hikes," said Bluestar Adisseo Chief Executive Officer Jean-Marc Dublanc at a video press conference for the company's Hong Kong initial public offering (IPO) later this month.

Bluestar Adisseo is offering 2.3 billion shares, or 25 percent of the company, at HK$3.50 to HK$5.25, its term sheet shows. At its upper end, this would amount to HK$12.08 million ($1.56 billion).

The company will use 40 percent of the IPO proceeds to expand and upgrade its European plants, and another 40 percent to develop its feed business.

Bluestar Adisseo's featured product, methionine, is an essential amino acid and a basic building block in the formation of proteins. It cannot be synthesized in the body but only assimilated indirectly through edible meat.

Methionine is now mainly used in feed to promote the growth of poultry and livestock, shorten feeding cycles, and increase the quantity of lean meat.

However, due to high technical barriers, there are only five licensers of methionine production technology in the world, and the market is concentrated among four main players which control more than 90 percent of global market share. Bluestar Adisseo ranks second.

Bluestar Adisseo also produces a diverse range of animal nutritional products including vitamins and enzyme. Its principal revenue is nevertheless more reliant on the sales of methionine, which accounted for 61.6 percent, 61.9 percent and 63.8 percent of its total revenue respectively between 2007 and 2009.

According to a new report from Global Industry Analysts released this year, the mainland is the second-largest manufacturer of animal feed, as well as being among the largest consumers of methionine in the world.

However, there is no methionine producer on the mainland currently, which has "an estimated annual demand of 120,000 tons," according to Xi Yuxin from China National Bluestar Group, which bought Adisseo Group for $480 million in 2006. China National Bluestar group is a unit of China National Chemical Corp.

"In fact, methionine's popularity has been stymied by the high cost of importing it," said Dan Chen, managing director of China Banking at Deutsche Bank, who added that the current dearth of Chinese producers will leave more room for Bluestar Adisseo to profit after it localizes production and lowers its costs.

The company announced in August 2009 that it plans to build a methionine plant in Nanjing, the first plant of its type on the mainland. It is expected to be operational by the second half of 2012 with an annual production capacity of 70,000 tons.

Robert Lu, chairman of Bluestar Adisseo, expects the group's net profit to rise at a rapid pace after the IPO in Hong Kong, due to the enormous prospects on the mainland market.

"Nutritional feed additives are definitely a very interesting concept for Hong Kong investors," said Linus Yip, a strategist at First Shanghai Securities.

"The good performance of other France-based companies like L'occitane after their listing may embed confidence on the local investors," Yip added.